Skip to main content

Table 2 Species distribution of 98 bacterial bloodstream isolates recovered from patients who received ciprofloxacin prophylaxis or not during neutropenia

From: Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance

Microorganism

Ciprofloxacin group

Control group

Gram-positive

N=28

N=24

  Coagulase-negative   staphylococci

14

16

  Staphylococcus aureus

4

1

  α- Hemolytic streptococci

5

4

  Other Gram-positive*

5

3

Gram-negative

N=29

N=17

  Escherichia coli

9

5

  Klebsiella pneumoniae

2

1

  Other enterobacteria**

4

4

  Pseudomonas aeruginosa

3

4

  Other non-fermentative   Gram-negative***

11

3

  1. The total number of isolates exceeds the number of bacteremias because there were 13 episodes of polymicrobial bacteremia.
  2. * Ciprofloxacin group: Enterococcus sp. and Streptococcus pneumoniae (1 each), and 3 Gram-positive rods; Control group: Enterococcus sp. (2) and Bacillus sp. (1).
  3. ** Ciprofloxacin group: Enterobacter sp. (3), and Shigella sp. (1); Control group: Citrobacter sp. (2), and Enterobacter sp. and Serratia sp. (1 each).
  4. *** Ciprofloxacin group: 5 Acinetobacter sp., 3 Stenotrophomonas maltophilia, and 3 Burkholderia cepacia; Control group: 1 Acinetobacter sp., 1 Stenotrophomonas maltophilia, and 1 Burkholderia cepacia.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us